<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00510666</url>
  </required_header>
  <id_info>
    <org_study_id>NMU-2579-3FW</org_study_id>
    <secondary_id>NMU2007092</secondary_id>
    <nct_id>NCT00510666</nct_id>
  </id_info>
  <brief_title>Comparison of Butorphanol and Tramadol Associated Patient-Controlled Analgesia (PCA) After Hysterectomy</brief_title>
  <acronym>BATPCAH</acronym>
  <official_title>Butorphanol and Tramadol for Morphine PCA Pain Management After Total Hysterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>HRSA/Maternal and Child Health Bureau</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intravenous patient-controlled analgesia (PCA) is a popular technique for postoperative pain
      management. Although several drugs are recognized as effective therapeutic options, optimal
      selection of drugs in hysterectomy patients underwent different anesthesia treatments remains
      unknown explicitly. The investigators hypothesized that butorphanol and tramadol can produce
      different analgesic effects with intravenous PCA after abdominal hysterectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">May 2007</completion_date>
  <primary_completion_date type="Actual">May 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS pain scoring;</measure>
    <time_frame>5 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>VAS sedation scoring; VAS happiness scoring; Adverse effects; Patient's overall conditions.</measure>
    <time_frame>5 months</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">841</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Hysterectomy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Butorphanol basal infusion adjunct to morphine PCA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Saline infusion adjunct to morphine PCA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Premedication of Tramadol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preemptive saline for morphine PCA</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Saline infusion adjunct to morphine PCA pump</description>
    <arm_group_label>2</arm_group_label>
    <other_name>SA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Butorphanol tartrate</intervention_name>
    <description>Butorphanol was delivered at a continuous infusion manner adjunct to morphine PCA pump</description>
    <arm_group_label>1</arm_group_label>
    <other_name>BT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol Hydrochloride</intervention_name>
    <description>100mg tramadol was used preemptively to morphine PCA pump</description>
    <arm_group_label>3</arm_group_label>
    <other_name>TH</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Preemptive saline as a control group to tramadol one</description>
    <arm_group_label>4</arm_group_label>
    <other_name>PS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA physical status I-II

          -  Chinese

          -  19-64yr

          -  Uterus myoma

        Exclusion Criteria:

          -  Allergy to opioids, a history of the use of centrally-acting drugs of any sort,
             chronic pain and psychiatric diseases records.

          -  Participants younger than 18yrï¼Œolder than 65yr or pregnancy was eliminated.

          -  Due to the significant changes in vital signs might affect cognition of pain and that
             of sensation, over 20% variation of these records from the baselines or below 92% of
             SpO2 under 20-40% nasal tube oxygen at any time should be excluded from the study.

          -  Those who were not willing to or could not finish the whole study at any time.

          -  Any patient who exhibited a combative or incoherent state of PCA analgesia would be
             excluded from the study.

          -  Allergy to local anesthetics.

          -  Failed to perform the epidural catheterization.

          -  Those who demonstrated significant nerve-associated side effects from the insertion of
             the epidural needle.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>XiaoFeng Shen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Nanjing Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nanjing Maternal and Child Care Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Wang F, Shen X, Liu Y, Xu S, Guo X. Continuous infusion of butorphanol combined with intravenous morphine patient-controlled analgesia after total abdominal hysterectomy: a randomized, double-blind controlled trial. Eur J Anaesthesiol. 2009 Jan;26(1):28-34. doi: 10.1097/EJA.0b013e32831a6aa2.</citation>
    <PMID>19122548</PMID>
  </results_reference>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2007</study_first_submitted>
  <study_first_submitted_qc>August 1, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2007</study_first_posted>
  <last_update_submitted>March 30, 2009</last_update_submitted>
  <last_update_submitted_qc>March 30, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 31, 2009</last_update_posted>
  <responsible_party>
    <name_title>XiaoFeng Shen</name_title>
    <organization>Nanjing Maternal and Child Health Hospital</organization>
  </responsible_party>
  <keyword>Pain, Postoperative</keyword>
  <keyword>Analgesics, Opioid</keyword>
  <keyword>Analgesia, Patient-Controlled</keyword>
  <keyword>Pain Measurement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Tramadol</mesh_term>
    <mesh_term>Butorphanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

